Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors - Liquidia (NASDAQ:LQDA), Emergent BioSolutions (NYSE:EBS)

GAITHERSBURG, Md., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with

Related Keywords

United States ,America ,Neal Fowler ,Eli Lilly ,Richard Lindahl ,Zsolt Harsanyi ,Mcneil Neurologics ,Don Degolyer ,Matt Hartwig ,Strong Women Foundation ,Master Of Business Administration ,Johnson ,Emergent Biosolutions Inc ,Novartis ,Exchange Commission ,University Of North Carolina At Chapel Hill ,Twitter ,Instagram ,Committee Of Sandoz ,Endo International ,Liquidia Corporation ,Pfizer ,Linkedin ,Sandoz Inc ,Fairleigh Dickinson University ,Pathalys Pharma Inc ,Centocor Inc ,University Of Rochester ,Compensation Committee ,Eshelman School Of Pharmacy Foundation ,Emergent Chairman ,Finance Committee ,Chief Executive Officer ,Pathalys Pharma ,Envisia Therapeutics ,Ortho Mcneil Neurologics ,Business Administration ,North Carolina ,Vertice Pharma ,Warburg Pincus ,Chief Operating Officer ,Executive Committee ,Strong Women ,Fairleigh Dickinson ,Private Securities Litigation Reform Act ,Media Relations ,Chief Financial ,